Health Insurance in South Korea will cover Zolgensma starting August of 2022! More info can be found below:
Zolgensma To Be Reimbursed in South Korea
This is great news for SMA patients in South Korea! After negotiations with Novartis, other countries had also agreed earlier to reimburse the one-time treatment, Zolgensma.
Belgium, Ireland, the Netherlands under the BeNeluxA Initiative
As always, thank you for your AMAZING support with this initiative. Please continue sharing our petition on social media as this greatly helps to spread the word about the issue around the exorbitant price of Zolgensma ($2.1 million). We hope more and more countries, globally, will begin covering the treatment in a near future if Novartis provides a discounted price for the treatment.
Here is the link to share:
Let's continue supporting this cause so that babies with SMA can get the treatment!
Thank you